A nonprofit biotechnology company based in Philadelphia has received $60 million from a TED initiative that funds "big ideas." The company, Every Cure, is using the money to further its mission of ...
Viridian Therapeutics is advancing its pipeline with positive phase 3 results for veligrotug in thyroid eye disease and plans a BLA submission in November 2025. VRDN is expanding its TED program with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results